Related Experiment Videos
Cytomegalovirus retinitis complicated by optic neuropathy: a longitudinal study
Journal of the American Optometric Association
|January 1, 1992
Summary
Ganciclovir effectively controlled cytomegalovirus (CMV) retinitis but led to optic neuropathy and vision loss in AIDS patients. Long-term visual function changes were documented for the first time.
Area of Science:
- Ophthalmology
- Virology
- Immunology
Background:
- Cytomegalovirus (CMV) retinitis is a serious opportunistic infection in individuals with Acquired Immunodeficiency Syndrome (AIDS).
- Ganciclovir is a primary antiviral treatment for CMV infections.
Observation:
- Two AIDS patients with suspected CMV retinitis were treated with ganciclovir.
- Patients were monitored for 18 and 5 months respectively.
- Optic neuropathy and reduced visual acuity were observed despite successful retinitis control.
Findings:
- Ganciclovir treatment controlled CMV retinitis in both cases.
- Both patients developed secondary optic neuropathy, leading to decreased vision.
- This study reports, for the first time, subjective visual function changes (perimetry, contrast sensitivity, accommodation) in long-term follow-up of AIDS patients with CMV retinitis.
Implications:
- Optic neuropathy is a significant complication of ganciclovir treatment for CMV retinitis in AIDS patients.
- Long-term monitoring of visual function is crucial for managing these patients.
- Further research is needed to understand and mitigate ganciclovir-induced ocular complications.